Endoluminal therapy for gastroesophageal reflux disease: is the evidence for efficacy any stronger?
Gastroesophageal reflux disease is a common disorder often requiring chronic treatment. Joining the conventional options of antisecretory medications and fundoplication, endoluminal therapies have emerged in recent years. These techniques have entered US and European markets, claiming effectiveness comparable with antireflux surgery. Nevertheless, a paucity of data is available to support that efficacy, even as more devices are coming onto the market. This review examines published reports of endoluminal reflux therapies from January 2004 to January 2005. After another year, there are still no compelling data supporting the efficacy of any of the available endoluminal treatments.
Lee
Thomas J
TJ
Feinberg School of Medicine, Division of Gastroenterology, Department of Medicine, Northwestern University, Chicago, IL 60611, USA.
Kahrilas
Peter J
PJ
D004945:Esophagoscopy / Q000379:methods / Q000592:standards / Q000639:trends; D005764:Gastroesophageal Reflux / Q000601:surgery*; D006801:Humans; D007391:International Cooperation; D016896:Treatment Outcome